AI-powered clinical evidence for drug development and precision medicine
HopeAI has raised $1.1M in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2024.
HopeAI's investors include Plug and Play, Taihill Venture, PKSHA Capital.
HopeAI is headquartered in Princeton, United States.
AI-powered clinical evidence for drug development and precision medicine
HopeAI is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HopeAI — Funding & Investors." VCBacked, January 15, 2024, https://www.vcbacked.co/company/hopeai. Accessed August 13, 2026.
VCBacked. (2024). HopeAI — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/hopeai
{{cite web |title=HopeAI — Funding & Investors |url=https://www.vcbacked.co/company/hopeai |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated